Pheno Therapeutics granted FDA IND clearance for lead multiple sclerosis therapeutic candidate PTD802
Pheno Therapeutics Limited. (Pheno), a clinical stage biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, today announced that the US…